Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations

By W. Aberer, A. Bircher, A. Romano, M. Blanca, P. Campi, Javier Fernández, K. Brockow, W. Pichler, P. Demoly, for Enda. Allergy. European Journal of Allergy and Clinical Immunology, 2003

843 citations recorded by the source corpus.

Subfields: Dermatology, Pharmacology, Physiology

View Paper: https://www.semanticscholar.org/paper/9bba274d52e88c21b450dae7d68c792731a3a5ac

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pharmacology

1. J. Tilch

Citations in the corpus

• The lymphocyte transformation test in the diagnosis of drug hypersensitivity (2004, background): “cofactors, which are not present during the time of provocation – thus also provocation tests can be false positive or false negative (36).”
• Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper (2013, background): “Before re-administration, a drug provocation test following ENDA recommendations is necessary (high/strong) (5).”
• International Consensus on drug allergy (2014, methodology): “The precise challenge procedure varies a great deal from one team to another, and guidelines for the performance of DPTs have been proposed (13).”